REGENXBIO Inc.
RGNX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001590877
In the last 90 days, REGENXBIO Inc. insiders filed 1 open-market purchase and 0 sales; 165 institutions reported holding it in 13F filings for Q2 2026, worth $504.6M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding REGENXBIO Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 181 | 1 | 186 | +6 |
| Shares | 43.8M | 8.61M | 43.7M | +8.52M (+24.3%) |
| Value | $511.9M | $100.7M | $458.1M | +$46.9M (+11.4%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (31)
Institutions that held REGENXBIO Inc. at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (25)
Institutions that held REGENXBIO Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Artal Group S.A. | 250,000 | $2.92M |
| Cubist Systematic Strategies, LLC | 188,235 | $2.20M |
| Gsa Capital Partners LLP | 151,753 | $1.78M |
| Norges Bank | 147,546 | $1.73M |
| Woodline Partners LP | 100,000 | $1.17M |
| Trexquant Investment LP | 89,605 | $1.05M |
| UBS Oconnor LLC | 70,199 | $821.3K |
| Walleye Capital LLC | 55,576 | $650.2K |
| Dynamic Technology Lab Private Ltd | 48,954 | $573.0K |
| Marshall Wace, LLP | 39,093 | $457.4K |
| Y-Intercept (Hong Kong) Ltd | 38,844 | $454.5K |
| PDT Partners, LLC | 34,412 | $402.6K |
| Wellington Management Group LLP | 32,652 | $382.0K |
| Engineers Gate Manager LP | 19,967 | $233.6K |
| Brevan Howard Capital Management LP | 15,222 | $178.1K |
| Redwood Wealth Management Group, LLC | 13,360 | $156.3K |
| Vident Advisory, LLC | 12,918 | $151.1K |
| Cornercap Investment Counsel Inc | 12,168 | $142.4K |
| First Manhattan Co | 10,600 | $124.0K |
| Point72 (DIFC) Ltd | 3,806 | $44.5K |
| Aquatic Capital Management LLC | 2,600 | $30.4K |
| Headlands Technologies LLC | 927 | $10.8K |
| Pacer Advisors, Inc. | 587 | $6.87K |
| Allspring Global Investments Holdings, LLC | 325 | $3.80K |
| Innealta Capital, LLC | 8 | $94 |
Not filed for Q3 2024 yet (1)
Institutions that held REGENXBIO Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 8,609,338 | $100.7M |